Arkolith/Insider Trading/CATX/Form 4

Williamson Robert F III

DirectorPerspective Therapeutics, Inc. (CATX) · full profile →Form 4 · filed Feb 1, 2024
Net Buying
Open-Market Buys
$91K
Open-Market Sells
$0
Net Open-Market Flow
$91K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2024Buy(P)43K$0.72$31K335K
Jan 30, 2024Buy(P)57K$0.71$41K292K
Jan 30, 2024Buy(P)5K$0.71$4K235K
Jan 30, 2024Buy(P)19K$0.71$13K230K
Jan 30, 2024Buy(P)4K$0.70$2K339K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-002837) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML